| Quarter | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|
| 314 | 298 | 294 | 347 | 361 | 342 | 353 | 422 | 441 | |
Growth YoY Revenue Growth YoY% | 15.1 | 15.0 | 20.2 | 21.9 | 22.2 | ||||
| 247 | 228 | 239 | 277 | 283 | 259 | 291 | 329 | 345 | |
| 67 | 69 | 54 | 70 | 78 | 83 | 62 | 93 | 96 | |
OPM OPM% | 21.3 | 23.3 | 18.5 | 20.1 | 21.7 | 24.3 | 17.6 | 22.1 | 21.8 |
| 2 | 1 | 2 | 2 | 2 | -17 | 4 | 3 | 3 | |
Interest Expense Interest ExpenseCr | 3 | 2 | 2 | 2 | 2 | 2 | 1 | 3 | 3 |
Depreciation DepreciationCr | 9 | 10 | 10 | 9 | 9 | 9 | 10 | 13 | 15 |
PBT PBTCr | 57 | 58 | 44 | 61 | 70 | 55 | 55 | 80 | 81 |
| 14 | 13 | 12 | 14 | 17 | 14 | 9 | 20 | 20 | |
| 43 | 45 | 32 | 46 | 52 | 41 | 45 | 60 | 60 | |
Growth YoY PAT Growth YoY% | 21.8 | -8.2 | 43.7 | 30.1 | 15.3 | ||||
NPM NPM% | 13.7 | 15.1 | 10.7 | 13.3 | 14.5 | 12.1 | 12.8 | 14.2 | 13.7 |
| 7.0 | 7.3 | 5.2 | 7.5 | 8.6 | 6.8 | 7.4 | 9.8 | 9.9 |
| Quarter | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|
| 314 | 298 | 294 | 347 | 361 | 342 | 353 | 422 | 441 | |
Growth YoY Revenue Growth YoY% | 15.1 | 15.0 | 20.2 | 21.9 | 22.2 | ||||
| 247 | 228 | 239 | 277 | 283 | 259 | 291 | 329 | 345 | |
| 67 | 69 | 54 | 70 | 78 | 83 | 62 | 93 | 96 | |
OPM OPM% | 21.3 | 23.3 | 18.5 | 20.1 | 21.7 | 24.3 | 17.6 | 22.1 | 21.8 |
| 2 | 1 | 2 | 2 | 2 | -17 | 4 | 3 | 3 | |
Interest Expense Interest ExpenseCr | 3 | 2 | 2 | 2 | 2 | 2 | 1 | 3 | 3 |
Depreciation DepreciationCr | 9 | 10 | 10 | 9 | 9 | 9 | 10 | 13 | 15 |
PBT PBTCr | 57 | 58 | 44 | 61 | 70 | 55 | 55 | 80 | 81 |
| 14 | 13 | 12 | 14 | 17 | 14 | 9 | 20 | 20 | |
| 43 | 45 | 32 | 46 | 52 | 41 | 45 | 60 | 60 | |
Growth YoY PAT Growth YoY% | 21.8 | -8.2 | 43.7 | 30.1 | 15.3 | ||||
NPM NPM% | 13.7 | 15.1 | 10.7 | 13.3 | 14.5 | 12.1 | 12.8 | 14.2 | 13.7 |
| 7.0 | 7.3 | 5.2 | 7.5 | 8.6 | 6.8 | 7.4 | 9.8 | 9.9 |
| Financial Year | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|
Revenue RevenueCr | 884 | 1,014 | 1,196 | 1,403 | 1,559 |
Growth Revenue Growth% | 14.8 | 17.9 | 17.3 | 20.0 | |
| 756 | 860 | 956 | 1,110 | 1,225 | |
| 128 | 155 | 240 | 293 | 334 | |
OPM OPM% | 14.5 | 15.3 | 20.1 | 20.9 | 21.4 |
| 7 | 6 | 6 | -8 | -7 | |
Interest Expense Interest ExpenseCr | 4 | 14 | 11 | 7 | 8 |
Depreciation DepreciationCr | 20 | 28 | 37 | 38 | 48 |
PBT PBTCr | 111 | 118 | 199 | 240 | 271 |
| 26 | 28 | 49 | 55 | 64 | |
PAT PATCr | 85 | 91 | 149 | 185 | 207 |
Growth PAT Growth% | 6.6 | 65.1 | 23.9 | 18.3 | |
NPM NPM% | 9.6 | 8.9 | 12.5 | 13.2 | 13.3 |
| 14.6 | 14.8 | 24.4 | 30.3 | 33.9 |
| Financial Year | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|
Revenue RevenueCr | 884 | 1,014 | 1,196 | 1,403 | 1,559 |
Growth Revenue Growth% | 14.8 | 17.9 | 17.3 | 20.0 | |
| 756 | 860 | 956 | 1,110 | 1,225 | |
| 128 | 155 | 240 | 293 | 334 | |
OPM OPM% | 14.5 | 15.3 | 20.1 | 20.9 | 21.4 |
| 7 | 6 | 6 | -8 | -7 | |
Interest Expense Interest ExpenseCr | 4 | 14 | 11 | 7 | 8 |
Depreciation DepreciationCr | 20 | 28 | 37 | 38 | 48 |
PBT PBTCr | 111 | 118 | 199 | 240 | 271 |
| 26 | 28 | 49 | 55 | 64 | |
PAT PATCr | 85 | 91 | 149 | 185 | 207 |
Growth PAT Growth% | 6.6 | 65.1 | 23.9 | 18.3 | |
NPM NPM% | 9.6 | 8.9 | 12.5 | 13.2 | 13.3 |
| 14.6 | 14.8 | 24.4 | 30.3 | 33.9 |
| Financial Year | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 |
|---|---|---|---|---|---|
Equity Capital Equity CapitalCr | 61 | 61 | 61 | 61 | 61 |
Reserves ReservesCr | 347 | 419 | 545 | 686 | 744 |
| 137 | 224 | 240 | 361 | 333 | |
| 49 | 126 | 84 | 97 | 109 | |
| 595 | 831 | 930 | 1,205 | 1,247 | |
| 291 | 290 | 339 | 348 | 474 | |
| 304 | 541 | 591 | 857 | 773 | |
| 595 | 831 | 930 | 1,205 | 1,247 |
| Financial Year | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 |
|---|---|---|---|---|---|
Equity Capital Equity CapitalCr | 61 | 61 | 61 | 61 | 61 |
Reserves ReservesCr | 347 | 419 | 545 | 686 | 744 |
| 137 | 224 | 240 | 361 | 333 | |
| 49 | 126 | 84 | 97 | 109 | |
| 595 | 831 | 930 | 1,205 | 1,247 | |
| 291 | 290 | 339 | 348 | 474 | |
| 304 | 541 | 591 | 857 | 773 | |
| 595 | 831 | 930 | 1,205 | 1,247 |
| Financial Year | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| 103 | 157 | 190 | 229 | |
| -50 | -267 | -84 | -256 | |
| -45 | 99 | -107 | 25 | |
Net Cash Flow Net Cash FlowCr | 8 | -11 | 0 | -1 |
Free Cash Flow Free Cash FlowCr | 9 | -129 | 99 | 56 |
CFO To PAT CFO To PAT% | 120.9 | 173.2 | 127.5 | 124.0 |
CFO To EBITDA CFO To EBITDA% | 80.3 | 101.3 | 79.4 | 78.2 |
| Financial Year | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| 103 | 157 | 190 | 229 | |
| -50 | -267 | -84 | -256 | |
| -45 | 99 | -107 | 25 | |
Net Cash Flow Net Cash FlowCr | 8 | -11 | 0 | -1 |
Free Cash Flow Free Cash FlowCr | 9 | -129 | 99 | 56 |
CFO To PAT CFO To PAT% | 120.9 | 173.2 | 127.5 | 124.0 |
CFO To EBITDA CFO To EBITDA% | 80.3 | 101.3 | 79.4 | 78.2 |
| Financial Year | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Current |
|---|---|---|---|---|---|
Market Cap Market CapitalizationCr | 9,517 | 13,842 | |||
Price To Earnings Price To Earnings | 51.4 | 66.9 | |||
Price To Sales Price To Sales | 6.8 | 8.9 | |||
Price To Book Price To Book | 12.7 | 17.2 | |||
EV To EBITDA EV To EBITDA | 32.9 | 41.5 | |||
GPM GPM% | 75.2 | 76.5 | 79.2 | 80.2 | 80.2 |
OPM OPM% | 14.5 | 15.3 | 20.1 | 20.9 | 21.4 |
NPM NPM% | 9.6 | 8.9 | 12.5 | 13.2 | 13.3 |
ROCE ROCE% | 26.4 | 20.8 | 30.2 | 27.1 | 31.1 |
ROE ROE% | 20.8 | 18.8 | 24.6 | 24.8 | 25.7 |
ROA ROA% | 14.3 | 10.9 | 16.1 | 15.4 | 16.6 |
| Financial Year | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Current |
|---|---|---|---|---|---|
Market Cap Market CapitalizationCr | 9,517 | 13,842 | |||
Price To Earnings Price To Earnings | 51.4 | 66.9 | |||
Price To Sales Price To Sales | 6.8 | 8.9 | |||
Price To Book Price To Book | 12.7 | 17.2 | |||
EV To EBITDA EV To EBITDA | 32.9 | 41.5 | |||
GPM GPM% | 75.2 | 76.5 | 79.2 | 80.2 | 80.2 |
OPM OPM% | 14.5 | 15.3 | 20.1 | 20.9 | 21.4 |
NPM NPM% | 9.6 | 8.9 | 12.5 | 13.2 | 13.3 |
ROCE ROCE% | 26.4 | 20.8 | 30.2 | 27.1 | 31.1 |
ROE ROE% | 20.8 | 18.8 | 24.6 | 24.8 | 25.7 |
ROA ROA% | 14.3 | 10.9 | 16.1 | 15.4 | 16.6 |
| Market CapitalizationMkt CapCr | 15,974 | 15,424 | 14,894 | 13,842 | 13,196 | 10,958 | 8,917 |
| Close PriceClose₹ | 814.30 | 2,029.10 | 935.05 | 2,263.20 | 291.15 | 696.20 | 967.30 |
| IndustryIndustry | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations |
| Price To EarningsPE | 17.74 | 22.38 | 56.29 | 66.86 | 23.56 | 29.30 | 14.46 |
| Price To SalesPS | 5.17 | 6.47 | 1.65 | 8.88 | 3.89 | 2.27 | 1.71 |
| RevenueRevenueCr | 3,089 | 2,383 | 9,012 | 1,559 | 3,392 | 4,826 | 5,213 |
| Revenue Growth TTMRev Gr TTM% | -29.6% | 16.8% | 18.3% | 20.0% | 24.2% | 17.5% | 11.3% |
| PAT Growth TTMPAT Gr TTM% | -56.4% | 17.4% | -44.7% | 18.3% | 60.2% | 12.8% | 54.3% |
| Market CapitalizationMkt CapCr | 15,974 | 15,424 | 14,894 | 13,842 | 13,196 | 10,958 | 8,917 |
| Close PriceClose₹ | 814.30 | 2,029.10 | 935.05 | 2,263.20 | 291.15 | 696.20 | 967.30 |
| IndustryIndustry | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations |
| Price To EarningsPE | 17.74 | 22.38 | 56.29 | 66.86 | 23.56 | 29.30 | 14.46 |
| Price To SalesPS | 5.17 | 6.47 | 1.65 | 8.88 | 3.89 | 2.27 | 1.71 |
| RevenueRevenueCr | 3,089 | 2,383 | 9,012 | 1,559 | 3,392 | 4,826 | 5,213 |
| Revenue Growth TTMRev Gr TTM% | -29.6% | 16.8% | 18.3% | 20.0% | 24.2% | 17.5% | 11.3% |
| PAT Growth TTMPAT Gr TTM% | -56.4% | 17.4% | -44.7% | 18.3% | 60.2% | 12.8% | 54.3% |